Solution Group going regional


Upon obtaining the approval, Solution Group deputy group managing director Datuk Mohd Nazlee Kamal (file pic) told StarBiz, the company would produce between 30 million and 40 million doses for this year. Some of the vaccines would also be exported to South-East Asian countries.

KUALA LUMPUR: Solution Group Bhd, which has inked a deal with China’s CanSino Biologics Inc for the distribution of the Covid-19 vaccines in Malaysia, has started to plan for bigger things ahead.

The engineering and biopharmaceuticals company is looking to export the vaccines to the South-East Asia region.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Oil prices edge higher after Russia-Ukraine tensions escalate
Malaysia-Brazil partnership instrumental to Yinson's success
Ringgit advances as domestic optimism offsets US rate concerns
Foreign investors record RM259.8mil weekly net outflow from Bursa Malaysia
Bursa Malaysia stays firmly below 1,600 amid weak regional sentiment
Trading ideas: MAHB, Sime Darby, Pantech, Barakah, Meta Bright, Mudajaya, Citaglobal, Cropmate, Sunsuria
MR DIY’s earnings to pick up in the fourth quarter
AI likely to add US$79bil to Vietnam’s economy by 2030
Boon or bane?
Fed refuses to back Basel climate plan, leaving talks in limbo

Others Also Read